Specific inhibition of myosin-Va and - Vb

特异性抑制肌球蛋白-Va 和-Vb

基本信息

  • 批准号:
    6822465
  • 负责人:
  • 金额:
    $ 28.93万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-07-01 至 2008-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Myosins are essential for intracellular transport, and mutations in the genes encoding them have been shown to cause several inherited diseases. The characterization of the specific cellular functions of unconventional myosins has lagged behind their identification for several reasons. First, there is a great deal of redundancy within families of related myosins. Several groups have identified specific functions by expressing the cargo-binding, or tail, domains of myosins; however, this approach fails to detect any functions dependent upon prior positioning by the motor domain and can yield nonspecific effects from high levels of expression. Second, the study of mutants has been employed. Although genetic ablation approaches are very powerful, null mutants often only illuminate the initial process for which a given myosin is essential during development, precluding the identification of later physiological functions. The ultimate goal of this research is to understand the roles of myosin-Va and -Vb in multiple cellular functions. To this end, a chemical-genetic strategy has been developed that achieves selectivity, specificity, and temporal control by enlarging the ATP-binding site of the myosin using site-directed mutagenesis. This sensitizes the myosin to inhibition by a specific ADP analog while still allowing it to hydrolyze cellular ATP. The acute application of the analog then causes tight binding to actin, arresting the movement of the sensitized mutant myosin. The experiments proposed in this application will test the hypothesis that myosin-Va and myosin-Vb function in initiation, maintenance, antagonism, or termination of microtubule-based motility, using specific inhibition in HeLa, PC 12, MDCK, and B16 cell lines as well as primary cells from transgenic and knock-in mutant mice.
描述(由申请人提供):

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOHN A MERCER其他文献

JOHN A MERCER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOHN A MERCER', 18)}}的其他基金

OLYMPUS FV1000 INVERTED SPECTRAL CONFOCAL SYSTEM
奥林巴斯 FV1000 倒光谱共焦系统
  • 批准号:
    7794254
  • 财政年份:
    2010
  • 资助金额:
    $ 28.93万
  • 项目类别:
Myosin-Va and axonal protein synthesis
肌球蛋白-Va 和轴突蛋白合成
  • 批准号:
    7758288
  • 财政年份:
    2008
  • 资助金额:
    $ 28.93万
  • 项目类别:
Myosin-Va and axonal protein synthesis
肌球蛋白-Va 和轴突蛋白合成
  • 批准号:
    7343624
  • 财政年份:
    2008
  • 资助金额:
    $ 28.93万
  • 项目类别:
Myosin-Va and axonal protein synthesis
肌球蛋白-Va 和轴突蛋白合成
  • 批准号:
    7544540
  • 财政年份:
    2008
  • 资助金额:
    $ 28.93万
  • 项目类别:
Specific inhibition of myosin-Va and - Vb
特异性抑制肌球蛋白-Va 和-Vb
  • 批准号:
    7255833
  • 财政年份:
    2004
  • 资助金额:
    $ 28.93万
  • 项目类别:
Specific inhibition of myosin-Va and - Vb
特异性抑制肌球蛋白-Va 和-Vb
  • 批准号:
    6913684
  • 财政年份:
    2004
  • 资助金额:
    $ 28.93万
  • 项目类别:
Specific inhibition of myosin-Va and - Vb
特异性抑制肌球蛋白-Va 和-Vb
  • 批准号:
    7088995
  • 财政年份:
    2004
  • 资助金额:
    $ 28.93万
  • 项目类别:
MYOSIN I BETA DISRUPTION & INNER EAR STRUCTURE/FUNCTION
肌球蛋白 I Beta 破坏
  • 批准号:
    6848672
  • 财政年份:
    1998
  • 资助金额:
    $ 28.93万
  • 项目类别:
MYOSIN I BETA DISRUPTION & INNER EAR STRUCTURE/FUNCTION
肌球蛋白 I Beta 破坏
  • 批准号:
    6703103
  • 财政年份:
    1998
  • 资助金额:
    $ 28.93万
  • 项目类别:
MYOSIN I BETA DISRUPTION & INNER EAR STRUCTURE/FUNCTION
肌球蛋白 I Beta 破坏
  • 批准号:
    6497127
  • 财政年份:
    1998
  • 资助金额:
    $ 28.93万
  • 项目类别:

相似海外基金

MDCK cell line evaluation
MDCK细胞系评估
  • 批准号:
    412774-2011
  • 财政年份:
    2011
  • 资助金额:
    $ 28.93万
  • 项目类别:
    Experience Awards (previously Industrial Undergraduate Student Research Awards)
Investigation the mechanism of renal stone formation by used the MDCK cell line.
利用MDCK细胞系研究肾结石形成的机制。
  • 批准号:
    11671547
  • 财政年份:
    1999
  • 资助金额:
    $ 28.93万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
MDCK CELL MUTANTS DEFECTIVE IN GLYCOPROTEIN MATURATION
MDCK 细胞突变体糖蛋白成熟缺陷
  • 批准号:
    3436819
  • 财政年份:
    1990
  • 资助金额:
    $ 28.93万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了